|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-9-27
|
|
pubmed:abstractText |
In the estrogen in venous thromboembolism (EVTET) study of 140 women with a history of venous thromboembolism (VTE), oral hormone replacement therapy (HRT) was associated with strong activation of coagulation markers and increased risk of recurrent VTE. No such associations were observed in the estrogen women atherosclerosis (EWA) study of 118 women with established coronary artery disease who were given transdermal HRT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estriol,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Medroxyprogesterone Acetate,
http://linkedlifedata.com/resource/pubmed/chemical/Norethindrone,
http://linkedlifedata.com/resource/pubmed/chemical/P-Selectin,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Trisequens,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Cell Adhesion Molecule-1
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0378-5122
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
16
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
111-8
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16186073-Administration, Cutaneous,
pubmed-meshheading:16186073-Administration, Oral,
pubmed-meshheading:16186073-Blood Coagulation,
pubmed-meshheading:16186073-C-Reactive Protein,
pubmed-meshheading:16186073-Drug Combinations,
pubmed-meshheading:16186073-Estradiol,
pubmed-meshheading:16186073-Estriol,
pubmed-meshheading:16186073-Female,
pubmed-meshheading:16186073-Hormone Replacement Therapy,
pubmed-meshheading:16186073-Humans,
pubmed-meshheading:16186073-Interleukin-6,
pubmed-meshheading:16186073-Medroxyprogesterone Acetate,
pubmed-meshheading:16186073-Middle Aged,
pubmed-meshheading:16186073-Norethindrone,
pubmed-meshheading:16186073-P-Selectin,
pubmed-meshheading:16186073-Risk Factors,
pubmed-meshheading:16186073-Transforming Growth Factor beta,
pubmed-meshheading:16186073-Tumor Necrosis Factor-alpha,
pubmed-meshheading:16186073-Vascular Cell Adhesion Molecule-1,
pubmed-meshheading:16186073-Venous Thrombosis
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
|
|
pubmed:affiliation |
Department of Hematology, Faculty Division, Ullevaal University Hospital, Oslo, Norway. a.l.eilertsen@medisin.uio.no
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
